Trimethoprim/Sulfamethoxazole (TMP/SMX)

DRUG2 trials

Sponsors

International Maternal Pediatric Adolescent AIDS Clinical Trials Group, Johns Hopkins University

Conditions

Cystic FibrosisHIV InfectionPneumocystis Jiroveci PneumoniaTuberculosis

Phase 2

Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV

TerminatedNCT00080119

International Maternal Pediatric Adolescent AIDS Clinical Trials GroupHIV Infection, Pneumocystis Jiroveci Pneumonia, Tuberculosis

Start: 2004-02-29End: 2009-05-31Updated: 2019-02-05

Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)

CompletedNCT01594827

Johns Hopkins UniversityCystic Fibrosis

Start: 2012-10-31End: 2017-12-30Updated: 2019-02-26

Related Papers

Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants Is Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants

PLoS ONE2016-02-1221 citations

Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis—the PMEP trial: study protocol for a randomized controlled trial

Trials2014-06-1228 citations

Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children.

2011-07-01113 citations